000 01388 a2200409 4500
005 20250516064316.0
264 0 _c20120125
008 201201s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0b013e31823a0cb6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMatthews, E
245 0 0 _aAcetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.
_h[electronic resource]
260 _bNeurology
_cNov 2011
300 _a1960-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAcetazolamide
_xpharmacology
650 0 4 _aCarbonic Anhydrase Inhibitors
_xpharmacology
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
_xgenetics
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aHypokalemic Periodic Paralysis
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPredictive Value of Tests
650 0 4 _aRetrospective Studies
700 1 _aPortaro, S
700 1 _aKe, Q
700 1 _aSud, R
700 1 _aHaworth, A
700 1 _aDavis, M B
700 1 _aGriggs, R C
700 1 _aHanna, M G
773 0 _tNeurology
_gvol. 77
_gno. 22
_gp. 1960-4
856 4 0 _uhttps://doi.org/10.1212/WNL.0b013e31823a0cb6
_zAvailable from publisher's website
999 _c21322026
_d21322026